Annual Working Capital
$2.88 M
-$4.20 M-59.35%
December 1, 2023
Summary
- As of March 1, 2025, NBY annual working capital is $2.88 million, with the most recent change of -$4.20 million (-59.35%) on December 1, 2023.
- During the last 3 years, NBY annual working capital has fallen by -$8.53 million (-74.79%).
- NBY annual working capital is now -84.19% below its all-time high of $18.19 million, reached on December 31, 2007.
Performance
NBY Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$295.00 K
+$1.65 M+121.74%
September 1, 2024
Summary
- As of March 1, 2025, NBY quarterly working capital is $295.00 thousand, with the most recent change of +$1.65 million (+121.74%) on September 1, 2024.
- Over the past year, NBY quarterly working capital has dropped by -$3.35 million (-91.90%).
- NBY quarterly working capital is now -98.38% below its all-time high of $18.19 million, reached on December 31, 2007.
Performance
NBY Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NBY Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.4% | -91.9% |
| 3 y3 years | -74.8% | -94.3% |
| 5 y5 years | -39.6% | -94.3% |
NBY Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.4% | at low | -97.0% | +121.7% |
| 5 y | 5-year | -74.8% | at low | -97.7% | +121.7% |
| alltime | all time | -84.2% | +2813.2% | -98.4% | +121.7% |
NovaBay Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $295.00 K(-121.7%) |
| Jun 2024 | - | -$1.36 M(+307.5%) |
| Mar 2024 | - | -$333.00 K(-111.6%) |
| Dec 2023 | $2.88 M(-59.3%) | $2.88 M(-21.1%) |
| Sep 2023 | - | $3.64 M(-29.3%) |
| Jun 2023 | - | $5.15 M(-5.9%) |
| Mar 2023 | - | $5.47 M(-22.7%) |
| Dec 2022 | $7.08 M(-27.3%) | $7.08 M(+2.5%) |
| Sep 2022 | - | $6.90 M(+19.0%) |
| Jun 2022 | - | $5.80 M(-24.6%) |
| Mar 2022 | - | $7.69 M(-20.9%) |
| Dec 2021 | $9.73 M(-14.7%) | $9.73 M(+12.8%) |
| Sep 2021 | - | $8.62 M(-17.0%) |
| Jun 2021 | - | $10.38 M(+3.1%) |
| Mar 2021 | - | $10.07 M(-11.8%) |
| Dec 2020 | $11.41 M(+208.9%) | $11.41 M(-12.3%) |
| Sep 2020 | - | $13.01 M(+71.0%) |
| Jun 2020 | - | $7.61 M(+218.2%) |
| Mar 2020 | - | $2.39 M(-35.3%) |
| Dec 2019 | $3.69 M(-22.4%) | $3.69 M(-40.9%) |
| Sep 2019 | - | $6.25 M(+50.7%) |
| Jun 2019 | - | $4.14 M(+143.6%) |
| Mar 2019 | - | $1.70 M(-64.3%) |
| Dec 2018 | $4.76 M(+18.6%) | $4.76 M(-22.6%) |
| Sep 2018 | - | $6.15 M(-20.3%) |
| Jun 2018 | - | $7.72 M(-19.4%) |
| Mar 2018 | - | $9.57 M(+138.4%) |
| Dec 2017 | $4.02 M(-60.4%) | $4.02 M(-14.1%) |
| Sep 2017 | - | $4.68 M(-25.0%) |
| Jun 2017 | - | $6.23 M(-13.8%) |
| Mar 2017 | - | $7.23 M(-28.8%) |
| Dec 2016 | $10.15 M(-9673.6%) | $10.15 M(-5.1%) |
| Sep 2016 | - | $10.69 M(+384.7%) |
| Jun 2016 | - | $2.21 M(+313.9%) |
| Mar 2016 | - | $533.00 K(-602.8%) |
| Dec 2015 | -$106.00 K | -$106.00 K(-105.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $1.92 M(-72.1%) |
| Jun 2015 | - | $6.88 M(+76.6%) |
| Mar 2015 | - | $3.90 M(+8.1%) |
| Dec 2014 | $3.61 M(-67.7%) | $3.61 M(-55.3%) |
| Sep 2014 | - | $8.06 M(-25.8%) |
| Jun 2014 | - | $10.86 M(-23.0%) |
| Mar 2014 | - | $14.10 M(+26.3%) |
| Dec 2013 | $11.16 M(-26.1%) | $11.16 M(+32.6%) |
| Sep 2013 | - | $8.42 M(-8.5%) |
| Jun 2013 | - | $9.20 M(-23.7%) |
| Mar 2013 | - | $12.06 M(-20.2%) |
| Dec 2012 | $15.11 M(+28.9%) | $15.11 M(+78.1%) |
| Sep 2012 | - | $8.48 M(+18.8%) |
| Jun 2012 | - | $7.14 M(-27.5%) |
| Mar 2012 | - | $9.86 M(-15.9%) |
| Dec 2011 | $11.72 M(+6.2%) | $11.72 M(-8.4%) |
| Sep 2011 | - | $12.80 M(+32.0%) |
| Jun 2011 | - | $9.70 M(+5.4%) |
| Mar 2011 | - | $9.20 M(-16.6%) |
| Dec 2010 | $11.03 M(-4.6%) | $11.03 M(+35.7%) |
| Sep 2010 | - | $8.13 M(-13.1%) |
| Jun 2010 | - | $9.35 M(-8.9%) |
| Mar 2010 | - | $10.27 M(-11.2%) |
| Dec 2009 | $11.57 M(+44.0%) | $11.57 M(+44.2%) |
| Sep 2009 | - | $8.02 M(+18.5%) |
| Jun 2009 | - | $6.77 M(-13.9%) |
| Mar 2009 | - | $7.87 M(-2.1%) |
| Dec 2008 | $8.03 M(-55.8%) | $8.03 M(-22.0%) |
| Sep 2008 | - | $10.30 M(-15.9%) |
| Jun 2008 | - | $12.25 M(-18.0%) |
| Mar 2008 | - | $14.93 M(-17.9%) |
| Dec 2007 | $18.19 M(+129.5%) | $18.19 M(+899.7%) |
| Sep 2007 | - | $1.82 M(-56.6%) |
| Jun 2007 | - | $4.20 M(-28.7%) |
| Mar 2007 | - | $5.88 M(-25.8%) |
| Dec 2006 | $7.93 M(+165.5%) | $7.93 M(+165.5%) |
| Dec 2005 | $2.98 M | $2.98 M |
FAQ
- What is NovaBay Pharmaceuticals annual working capital?
- What is the all time high annual working capital for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual working capital year-on-year change?
- What is NovaBay Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly working capital year-on-year change?
What is NovaBay Pharmaceuticals annual working capital?
The current annual working capital of NBY is $2.88 M
What is the all time high annual working capital for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual working capital is $18.19 M
What is NovaBay Pharmaceuticals annual working capital year-on-year change?
Over the past year, NBY annual working capital has changed by -$4.20 M (-59.35%)
What is NovaBay Pharmaceuticals quarterly working capital?
The current quarterly working capital of NBY is $295.00 K
What is the all time high quarterly working capital for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly working capital is $18.19 M
What is NovaBay Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, NBY quarterly working capital has changed by -$3.35 M (-91.90%)